Cornell pre-diagnosis Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series B
  • Investors
  • 4

Cornell pre-diagnosis General Information

Description

Developer of a medical mobile platform created to focus on the health of women and babies. The company's product provides maternal care, medical and health information services for women and babies, enabling its clients to get access to national famous doctors and get maternal and child health consultation respond within 15 minutes.

Contact Information

Website
www.kangda.cn
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Information Services (B2C)
Other Industries
Other Healthcare Technology Systems
Application Software
Vertical Market Software
Primary Office
  • Second Floor, A
  • 70 Licheng Road, Pudong New Area
  • Shanghai
  • China
+86 140 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cornell pre-diagnosis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 12-Apr-2016 Completed Generating Revenue
2. Early Stage VC (Series A) 13-May-2015 Completed Generating Revenue
1. Seed Round 01-Oct-2013 Completed Startup
To view Cornell pre-diagnosis’s complete valuation and funding history, request access »

Cornell pre-diagnosis Executive Team (1)

Name Title Board Seat Contact Info
Weiming Lu Chief Executive Officer & Founder
To view Cornell pre-diagnosis’s complete executive team members history, request access »

Cornell pre-diagnosis Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Trustbridge Partners Growth/Expansion Minority 000 0000 000000 0
DCM Ventures Venture Capital Minority 000 0000 000000 0
Infinity Ventures Venture Capital Minority 000 0000 000000 0
Sequoia Capital China Venture Capital Minority 000 0000 000000 0
To view Cornell pre-diagnosis’s complete investors history, request access »